DARIOHEALTH CORP (DRIO) Stock Earnings & Estimates
USA - NASDAQ:DRIO - US23725P3082 - Common Stock
8.76 USD
+0.98 (+12.6%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 27.66M 34.86% | 20.352M -26.42% | 27.04M 32.86% | 24.715M -8.60% | 40.116M 62.31% | 38.769M -3.36% | 52.959M 36.60% | 62.751M 18.49% | 279.13M 344.82% | |
| EBITDA YoY % growth | -52.09M 28.81% | -51.204M 1.70% | -49.46M 3.41% | -17.055M 65.52% | -6.077M 64.37% | -814.98K 86.59% | 2.599M 418.90% | 6.685M 157.21% | N/A | |
| EBIT YoY % growth | -56.81M 25.73% | -56.189M 1.09% | -56.887M -1.24% | -33.944M 40.33% | -11.451M 66.27% | -8.824M 22.94% | N/A | N/A | N/A | |
| Operating Margin | -205.39% | -276.09% | -210.38% | -137.34% | -28.54% | -22.76% | N/A | N/A | N/A | |
| EPS YoY % growth | -2.63 37.08% | -2.02 23.19% | -8.60 -325.74% | -0.48 94.37% | -0.86 -77.89% | -1.17 -36.09% | 1.63 239.13% | 1.84 12.50% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -4.83 3.44% | -4.42 -145.56% | -3.16 -12.93% | -2.35 34.83% | -0.12 97.57% | -0.11 97.58% | -0.27 91.61% | -0.29 87.83% | -0.31 -160.87% | -0.33 -204.76% |
| Revenue Q2Q % growth | 5.868M -20.95% | 6.484M -14.73% | 8.945M 32.48% | 10.613M 97.67% | 13.841M 135.87% | 15.555M 139.90% | 11.302M 26.35% | 11.628M 9.56% | 11.924M -13.85% | 12.271M -21.11% |
| EBITDA Q2Q % growth | -5.871M 12.87% | -4.053M 4.06% | -3.509M 56.96% | -2.163M 69.71% | -1.116M 80.99% | -526.32K 87.02% | -1.989M 43.31% | -841.5K 61.10% | -62.22K 94.42% | -220.32K 58.14% |
| EBIT Q2Q % growth | -8.698M 27.70% | -6.265M 46.23% | -6.108M 35.09% | -3.497M 61.99% | 2.252M 125.89% | 5.094M 181.31% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -3.60 -125.00% | -4.76 | 1.16 | 24.37% |
| Q1 2025 Q2Q % growth | -2.80 -1,300.00% | -2.38 | -0.42 | -17.64% |
| Q4 2024 Q2Q % growth | -1.80 -260.00% | -6.80 | 5.00 | 73.53% |
| Q3 2024 Q2Q % growth | -5.00 -920.41% | -5.58 | 0.58 | 10.33% |
| Q2 2024 Q2Q % growth | -1.60 -175.86% | -11.32 | 9.72 | 85.87% |
| Q1 2024 Q2Q % growth | -0.20 55.56% | -0.41 | 0.21 | 51.59% |
| Q4 2023 Q2Q % growth | -0.50 1.96% | -0.56 | 0.06 | 11.41% |
| Q3 2023 Q2Q % growth | -0.49 23.44% | -0.47 | -0.02 | -4.43% |
| Q2 2023 Q2Q % growth | -0.58 21.62% | -0.53 | -0.05 | -8.93% |
| Q1 2023 Q2Q % growth | -0.45 39.19% | -0.51 | 0.06 | 11.41% |
| Q4 2022 Q2Q % growth | -0.51 53.21% | -0.67 | 0.16 | 23.31% |
| Q3 2022 Q2Q % growth | -0.64 45.76% | -0.78 | 0.14 | 17.75% |
| Q2 2022 Q2Q % growth | -0.74 25.25% | -0.73 | -0.01 | -1.82% |
| Q1 2022 Q2Q % growth | -0.74 19.57% | -0.98 | 0.24 | 24.20% |
| Q4 2021 Q2Q % growth | -1.09 -2.83% | -1.08 | -0.01 | -1.22% |
| Q3 2021 Q2Q % growth | -1.18 -66.20% | -0.95 | -0.23 | -23.63% |
| Q2 2021 Q2Q % growth | -0.99 -45.59% | -0.87 | -0.12 | -13.52% |
| Q1 2021 Q2Q % growth | -0.92 41.40% | -1.06 | 0.14 | 13.41% |
| Q4 2020 Q2Q % growth | -1.06 86.27% | -0.83 | -0.23 | -27.98% |
| Q3 2020 Q2Q % growth | -0.71 40.83% | -0.70 | -0.01 | -1.87% |
| Q2 2020 Q2Q % growth | -0.68 73.85% | -1.43 | 0.75 | 52.30% |
| Q1 2020 Q2Q % growth | -1.57 47.67% | -0.77 | -0.81 | -105.23% |
| Q4 2019 Q2Q % growth | -7.72 | -1.04 | -6.68 | -642.02% |
| Q3 2019 Q2Q % growth | -1.20 | -1.84 | 0.64 | 34.64% |
| Q2 2019 Q2Q % growth | -2.60 | -2.75 | 0.15 | 5.59% |
| Q1 2019 Q2Q % growth | -3.00 | -2.65 | -0.35 | -13.12% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 5.369M -14.16% | 7.044M | -1.675M | -23.78% |
| Q1 2025 Q2Q % growth | 6.752M 17.26% | 7.625M | -873K | -11.45% |
| Q4 2024 Q2Q % growth | 7.604M 110.29% | 7.535M | 69K | 0.92% |
| Q3 2024 Q2Q % growth | 7.423M 111.00% | 7.545M | -122K | -1.62% |
| Q2 2024 Q2Q % growth | 6.255M 1.67% | 8.072M | -1.817M | -22.51% |
| Q1 2024 Q2Q % growth | 5.758M -18.51% | 6.893M | -1.135M | -16.47% |
| Q4 2023 Q2Q % growth | 3.616M -46.90% | 3.643M | -27K | -0.74% |
| Q3 2023 Q2Q % growth | 3.518M -46.78% | 5.449M | -1.931M | -35.44% |
| Q2 2023 Q2Q % growth | 6.152M -0.45% | 6.588M | -436K | -6.62% |
| Q1 2023 Q2Q % growth | 7.066M -12.33% | 6.838M | 228K | 3.33% |
| Q4 2022 Q2Q % growth | 6.81M 12.94% | 6.413M | 397K | 6.19% |
| Q3 2022 Q2Q % growth | 6.61M 17.41% | 6.357M | 253K | 3.98% |
| Q2 2022 Q2Q % growth | 6.18M 17.49% | 8.4M | -2.22M | -26.43% |
| Q1 2022 Q2Q % growth | 8.06M 123.89% | 7.012M | 1.048M | 14.95% |
| Q4 2021 Q2Q % growth | 6.03M 189.90% | 6.17M | -140K | -2.27% |
| Q3 2021 Q2Q % growth | 5.63M 175.98% | 5.889M | -259K | -4.40% |
| Q2 2021 Q2Q % growth | 5.26M 193.85% | 5.186M | 74K | 1.43% |
| Q1 2021 Q2Q % growth | 3.6M 115.57% | 4.044M | -444K | -10.98% |
| Q4 2020 Q2Q % growth | 2.08M 15.56% | 2.126M | -46K | -2.16% |
| Q3 2020 Q2Q % growth | 2.04M 9.09% | 1.993M | 47K | 2.36% |
| Q2 2020 Q2Q % growth | 1.79M 8.48% | 1.586M | 204K | 12.86% |
| Q1 2020 Q2Q % growth | 1.67M -25.45% | 1.785M | -115K | -6.44% |
| Q4 2019 Q2Q % growth | 1.8M | 2.091M | -291K | -13.92% |
| Q3 2019 Q2Q % growth | 1.87M | 1.938M | -68K | -3.51% |
| Q2 2019 Q2Q % growth | 1.65M | 2.499M | -849K | -33.97% |
| Q1 2019 Q2Q % growth | 2.24M | 2.55M | -310K | -12.16% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3738% | -2327.38% | 0% | 41.72% |
| Revenue | -13.83% | -26.38% | -9.27% | -19.58% |